Recall Radar

Disclaimer: Recall Radar is an informational summary of public FDA enforcement reports. It is not medical advice. Always confirm details with the FDA, the company, a pharmacist, or a doctor before making health decisions.

← All recalls · Drug recalls

Class IDrug

Epinephrine Injection recall

Summary

American Regent, Inc. is recalling Epinephrine Injection (drug). According to the FDA report, the reason is: Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials. The FDA rated this a Class I: most serious: there is a reasonable chance the product could cause serious health problems or death. Recall status: Ongoing.

Understanding this recall

What happened

American Regent is recalling Epinephrine Injection 30 mL multiple-dose vials because particles (nylon, cellulosic, acrylic, polyethylene and glass) were found, sterility can't be assured, and some vials were broken or leaking.

Why it matters

Medicines given by injection or IV go straight into the bloodstream, so they must be free of visible and sub-visible particles. Particles such as glass, metal or plastic in an injectable can, in principle, block small blood vessels or cause irritation, inflammation or clots. That risk is why the FDA treats particulate matter in injectables seriously. Broken or leaking vials and lack of sterility assurance add an infection risk on top of the particulate concern.

Who should pay attention

Hospital, clinic and pharmacy staff who stock epinephrine 30 mL vials.
Distribution in the FDA report: Nationwide within the U.S.A

How to check your product

Check the lot number and expiration date on the vial and carton.
Codes listed by the FDA: Lots: 25128L1C0, Exp. August 31, 2026; 25280L1C0, Exp. October 31, 2026; 26108L1C0, Exp. July 31, 2027

Based only on the FDA enforcement record plus general public-health background on this type of hazard. Not medical advice; if you have symptoms or concerns, contact a doctor or pharmacist.

Details from the FDA report

Product
Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous Infusion, intramuscular and Subcutaneous Use, AMERICAN REGENT INC., SHIRLEY, NY 11967. NDC 0517-3030-01
Reason
Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.
Lot / code info
Lots: 25128L1C0, Exp. August 31, 2026; 25280L1C0, Exp. October 31, 2026; 26108L1C0, Exp. July 31, 2027
Quantity
31,935 30mL-vials
Distribution
Nationwide within the U.S.A
Recalling company
American Regent, Inc., Shirley, NY United States
Recall started
August 11, 2026
FDA report date
September 16, 2026
Classification
Class I: Most serious: there is a reasonable chance the product could cause serious health problems or death.
Voluntary / mandated
Voluntary: Firm initiated
Status
Ongoing
Recall number
D-0865-2026

What to do

View the FDA source record (openFDA) · FDA recalls page

Helpful guides

All guides

Get recall alerts by email

One short digest when new FDA food, supplement or drug recalls are posted, with the most serious (Class I) first. Free; unsubscribe anytime.

Powered by Buttondown. You may need to confirm your address by email.